We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLOO:NASDAQGloo Holdings, Inc. Analysis

Data as of 2026-07-23 - not real-time

$3.28

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Gloo Holdings trades at $3.28, well below its 52‑week high of $9.98 and just above the calculated support of $2.94. The RSI of 34 signals that the stock is in oversold territory, while the MACD histogram turned positive, giving a bullish signal. Volume is on an increasing trend, supporting the technical rebound. Valuation metrics show a forward P/E of 10.9 versus an industry average of 33.7, indicating a substantial discount. The price‑to‑book of 2.17 and upside/downside potential of +276% further underline the cheapness. However, fundamentals are weak: operating margin is –45%, net loss per share of –$1.83 and negative operating cash flow.
The recent underwritten public offering raised $22.75 million, adding liquidity and extending the runway. Debt‑to‑equity sits at 29%, modest for a company of this size, and beta of 0.54 suggests lower market volatility relative to the S&P 500. Yet 30‑day volatility is extremely high at roughly 99%, reflecting price swings. The “Extreme Greed” reading on the Fear & Greed Index indicates strong market appetite for risk‑on stocks. With a market cap of $287 million and a niche AI‑driven platform for faith‑based organizations, the growth narrative hinges on scaling subscriptions. In sum, the stock presents a high‑reward, high‑risk profile that may appeal to investors comfortable with volatility.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI and bullish MACD signal a near‑term bounce
  • Recent capital raise improves cash runway
  • Technical support level near current price

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Continued revenue growth potential but negative margins
  • High price volatility may cause wide swing range
  • Valuation still attractive relative to industry peers

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued forward P/E versus industry average
  • Large upside potential indicated by upside/downside metric
  • Niche AI platform with scalable subscription model

Key Metrics & Analysis

Financial Health

Revenue Growth237.60%
Profit Margin-119.10%
P/E Ratio10.9
ROE-188.07%
Debt/Equity29.04
P/B Ratio2.2
Op. Cash Flow$-76435000
Industry P/E33.7

Technical Analysis

TrendBearish
RSI34.2
Support$2.94
Resistance$4.97
MA 20$3.77
MA 50$4.67
MA 200$5.86
MACDBullish
VolumeIncreasing
Fear & Greed Index87.73

Valuation

Target Price$12.33
Upside/Downside276.02%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.54
Volatility98.72%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.